To illustrate that, patients with type 1 diabetes who are almost exclusively treated with exogenous insulin are more prone to develop diabetic retinopathy after initiation of treatment as opposed to those with type 2 diabetes. The gene discussed is INS; the disease is type 2 diabetes mellitus.